Methergine should not be given to a patient experiencing postpartum hemorrhage with which of the following conditions?

Methergine should not be given to a patient experiencing postpartum hemorrhage with which of the following conditions?

• A. Renal disease
• B. Asthma
• C. Hypertension
• D. Diabetes

Answer: (C)

Methergine, or methylergometrine, is contraindicated in patients with hypertension due to its vasoconstrictive properties. It is often used after delivery to promote uterine contractions and reduce postpartum hemorrhage; however, in patients with pre-existing high blood pressure or hypertensive disorders, administering Methergine can lead to severe hypertension and hypertensive crisis. This makes it particularly dangerous for those with any type of hypertension. In contrast, while renal disease, asthma, and diabetes may present certain management considerations when using medications, they do not carry the same level of risk as hypertension does with Methergine. In patients with renal issues, care must be taken with drug clearance and dosing, but it is not an absolute contraindication. Asthma may require monitoring for bronchospasm but is not a direct contraindication either. Diabetes management may be affected, but Methergine does not pose a critical risk like it does for individuals with hypertension. Thus, hypertension is the condition that specifically contraindicates the use of Methergine in a postpartum hemorrhage scenario.

Methergine, or methylergometrine, is contraindicated in patients with hypertension due to its vasoconstrictive properties. It is often used after delivery to promote uterine contractions and reduce postpartum hemorrhage; however, in patients with pre-existing high blood pressure or hypertensive disorders, administering Methergine can lead to severe hypertension and hypertensive crisis. This makes it particularly dangerous for those with any type of hypertension.

In contrast, while renal disease, asthma, and diabetes may present certain management considerations when using medications, they do not carry the same level of risk as hypertension does with Methergine. In patients with renal issues, care must be taken with drug clearance and dosing, but it is not an absolute contraindication. Asthma may require monitoring for bronchospasm but is not a direct contraindication either. Diabetes management may be affected, but Methergine does not pose a critical risk like it does for individuals with hypertension. Thus, hypertension is the condition that specifically contraindicates the use of Methergine in a postpartum hemorrhage scenario.